Home › Therapeutic areas › Neurology › Chronic Inflammatory Demyelinating Polyneuropathy
Chronic Inflammatory Demyelinating Polyneuropathy (1 companies)
Companies with an active program in Chronic Inflammatory Demyelinating Polyneuropathy.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| IMVT | Immunovant | ImmunologyNeurology Rare | 1 | Phase 3 | $6.31B | 5 |
No companies match.